Atrial natriuretic peptide (ANP) is a hormone your heart releases to lower blood pressure and reduce blood volume. It works by signaling your kidneys to flush out extra sodium and water, relaxing your blood vessels, and counteracting hormones that raise blood pressure. Think of it as your body’s built-in pressure relief valve, activated when the heart senses it’s being stretched by too much fluid.
How ANP Gets Released
ANP is produced by specialized muscle cells in the upper chambers of your heart, particularly the right atrium. These cells contain tiny hormone-producing granules that sit ready to deploy. When blood volume rises too high or blood pressure climbs, the atrial walls stretch. That physical stretch is the primary trigger: it tells those cardiac muscle cells to release ANP into the bloodstream.
This makes the release mechanism elegantly simple. Your heart doesn’t need a signal from the brain or another organ. It directly senses the excess pressure against its own walls and responds by pumping out ANP to correct the problem. The hormone begins working within minutes, targeting the kidneys, blood vessels, and other organs simultaneously.
What ANP Does in the Kidneys
The kidneys are ANP’s primary target. When ANP arrives there, it does two things at once. First, it widens the blood vessels leading into the kidney’s filtering units while narrowing the ones leading out. This increases the rate at which blood gets filtered, pushing more fluid through. Second, ANP blocks the reabsorption of sodium in the kidney’s collecting ducts, the final stop before urine is formed. Normally, your kidneys reclaim most of the sodium passing through them. ANP tells them to let more of it go.
Because water follows sodium, the result is a significant increase in urine output. You lose both salt and water, which directly reduces blood volume and, in turn, blood pressure. This process is called natriuresis (sodium excretion), which is where the “natriuretic” in the hormone’s name comes from.
Effects on Blood Vessels and Other Hormones
Beyond the kidneys, ANP relaxes the smooth muscle lining your blood vessels, causing them to dilate. Wider vessels mean lower resistance to blood flow and lower blood pressure.
ANP also suppresses the renin-angiotensin-aldosterone system (RAAS), which is your body’s main blood-pressure-raising pathway. RAAS normally tells the kidneys to hold onto sodium and water when blood pressure drops. By dialing down this system, ANP removes the brakes on sodium and water loss. It also inhibits the release of aldosterone from the adrenal glands, a hormone that would otherwise signal the kidneys to reabsorb sodium. The net effect is a coordinated, multi-pronged push to bring blood pressure and fluid volume back to normal.
ANP and Fat Metabolism
One of ANP’s more surprising roles has nothing to do with blood pressure. Research published in the journal Diabetes found that ANP promotes the breakdown of stored fat in humans. When ANP binds to receptors on fat cells, it triggers a signaling chain that activates an enzyme responsible for breaking triglycerides into free fatty acids, a process called lipolysis.
In a controlled study, ANP infusion led to a 50% increase in circulating glycerol and free fatty acids compared to placebo, markers that fat stores were being actively broken down. This was accompanied by a 15% increase in the rate at which the body burned fat for energy, along with a measurable rise in overall energy expenditure after a meal. The fat breakdown occurred specifically in subcutaneous fat tissue (the fat just under your skin) rather than in muscle. Interestingly, this lipolytic effect appears to be unique to primates. It has been observed in humans and macaques but not in rodents or other commonly studied animals.
ANP Levels in Health and Disease
In healthy adults, average ANP levels in the blood run around 17.8 pg/mL, with no meaningful difference between men and women. These levels stay relatively stable under normal conditions.
Heart failure changes the picture dramatically. When the heart struggles to pump effectively, blood backs up and stretches the atrial walls persistently, driving ANP production much higher than normal. A study of patients with heart failure found mean ANP levels of about 30 pmol/L, roughly triple the 11 pmol/L seen in healthy controls. This elevation makes ANP (and its close relative, BNP) useful as a diagnostic marker. Doctors can measure these peptides with a blood test to help determine whether symptoms like shortness of breath and swelling are caused by heart failure. Levels also respond to treatment: in one study, patients treated with a type of blood pressure medication saw their ANP levels drop significantly over six months, suggesting the heart was under less strain.
ANP vs. BNP
ANP and BNP (B-type natriuretic peptide) are close relatives. Both are produced by heart muscle cells, both lower blood pressure, and both increase sodium excretion. The key differences are where they come from and when they become most clinically relevant.
ANP is released primarily from the atria in response to acute stretching. BNP is released mainly from the ventricles (the heart’s larger, lower chambers) and tends to rise more in response to sustained pressure overload and chronic heart failure. In clinical practice, BNP and its inactive fragment NT-proBNP are tested more frequently than ANP because they are more stable in blood samples and have been studied more extensively as diagnostic tools. But biologically, ANP and BNP work through the same receptor system and serve overlapping protective functions. Elevated levels of either one signal that the heart is working harder than it should be.